T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
1-Year Return 25.8%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
+14.72%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$816B
AUM Growth
+$72B
Cap. Flow
-$11.8B
Cap. Flow %
-1.45%
Top 10 Hldgs %
32.14%
Holding
3,020
New
107
Increased
1,941
Reduced
738
Closed
62

Sector Composition

1 Technology 32.25%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.37%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INFA icon
751
Informatica
INFA
$7.56B
$45.1M 0.01%
1,289,958
+73,655
+6% +$2.58M
PEB icon
752
Pebblebrook Hotel Trust
PEB
$1.4B
$45.1M 0.01%
2,928,450
-169,182
-5% -$2.61M
DD icon
753
DuPont de Nemours
DD
$32.7B
$45M 0.01%
587,254
+12,646
+2% +$970K
NTLA icon
754
Intellia Therapeutics
NTLA
$1.23B
$44.7M 0.01%
1,625,051
-209,092
-11% -$5.75M
VST icon
755
Vistra
VST
$69.1B
$44.6M 0.01%
640,976
+94,842
+17% +$6.61M
EHC icon
756
Encompass Health
EHC
$12.8B
$44.6M 0.01%
540,519
+464,897
+615% +$38.4M
VICI icon
757
VICI Properties
VICI
$35.4B
$44.6M 0.01%
1,496,576
+29,145
+2% +$868K
STT icon
758
State Street
STT
$32B
$44.6M 0.01%
576,333
+105,710
+22% +$8.17M
HLNE icon
759
Hamilton Lane
HLNE
$6.75B
$44.5M 0.01%
394,806
+51,452
+15% +$5.8M
ALAB icon
760
Astera Labs
ALAB
$38.7B
$44.5M 0.01%
+600,000
New +$44.5M
TENB icon
761
Tenable Holdings
TENB
$3.7B
$44.4M 0.01%
898,744
+7,258
+0.8% +$359K
CVCO icon
762
Cavco Industries
CVCO
$4.39B
$44.2M 0.01%
110,832
-247
-0.2% -$98.6K
PPL icon
763
PPL Corp
PPL
$26.6B
$44.2M 0.01%
1,605,778
-2,039,483
-56% -$56.1M
CGON icon
764
CG Oncology
CGON
$2.53B
$43.6M 0.01%
+992,118
New +$43.6M
SKY icon
765
Champion Homes, Inc.
SKY
$4.31B
$43.2M 0.01%
507,690
-248
-0% -$21.1K
TER icon
766
Teradyne
TER
$18.4B
$43.1M 0.01%
382,264
-494,264
-56% -$55.8M
WTW icon
767
Willis Towers Watson
WTW
$33.2B
$42.6M 0.01%
154,973
+6,118
+4% +$1.68M
XYL icon
768
Xylem
XYL
$34.5B
$42.1M 0.01%
325,496
+1,732
+0.5% +$224K
DAL icon
769
Delta Air Lines
DAL
$39.5B
$41.8M 0.01%
872,836
+8,797
+1% +$421K
ANSS
770
DELISTED
Ansys
ANSS
$41.7M 0.01%
120,214
-96,670
-45% -$33.6M
NTAP icon
771
NetApp
NTAP
$25B
$41.4M 0.01%
393,975
+111,439
+39% +$11.7M
DIOD icon
772
Diodes
DIOD
$2.52B
$41.3M 0.01%
585,261
-19,373
-3% -$1.37M
BEAM icon
773
Beam Therapeutics
BEAM
$2.18B
$41.2M 0.01%
1,246,189
+1,207,699
+3,138% +$39.9M
CHE icon
774
Chemed
CHE
$6.67B
$40.9M 0.01%
63,733
+32,752
+106% +$21M
CRSP icon
775
CRISPR Therapeutics
CRSP
$5.08B
$40.9M 0.01%
600,234
-264,112
-31% -$18M